A68930: a potent agonist selective for the dopamine D1 receptor (Q34546441)

2 August 2017

A68930: a potent agonist selective for the dopamine D1 receptor (English)

1 reference

2 August 2017

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

28 October 2022

author name string

DeNinno MP

1

1 reference

2 August 2017

MacKenzie R

3

1 reference

2 August 2017

M. P. DeNinno

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1683288

28 October 2022

R. Schoenleber

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1683288

28 October 2022

R. MacKenzie

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1683288

28 October 2022

D. R. Britton

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1683288

28 October 2022

K. E. Asin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1683288

28 October 2022

C. Briggs

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1683288

28 October 2022

J. M. Trugman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1683288

28 October 2022

M. Ackerman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1683288

28 October 2022

L. Artman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1683288

28 October 2022

L. Bednarz

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1683288

28 October 2022

language of work or name

English

0 references

publication date

1 June 1991

1 reference

2 August 2017

25 June 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1683288

full work available at URL

28 October 2022

https://api.elsevier.com/content/article/PII:0014299991904594?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

https://api.elsevier.com/content/article/PII:0014299991904594?httpAccept=text/plain

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

European Journal of Pharmacology

28 October 2022

published in

1 reference

2 August 2017

199

1 reference

2 August 2017

2

1 reference

2 August 2017

209-219

1 reference

Opposite effects of stimulation of D1 and D2 dopamine receptors on the expression of motor seizures in mouse and rat

2 August 2017

1

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

Proconvulsant effect of SKF 38393 mediated by nigral D1 receptors

28 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

The functional anatomy of basal ganglia disorders

28 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

Thienopyridine derivatives identified as the first selective, full efficacy, dopamine D1 receptor agonists

28 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats

28 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

Dopamine D1 receptor modulation of pilocarpine-induced convulsions

28 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

N,N-disubstituted 2-aminotetralins are potent D-2 dopamine receptor agonists

28 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands

28 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

Selective D-1 dopamine receptor agonist treatment of Parkinson's disease

28 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist.

28 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

(1R,3S)-1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-3-phenyl-1H-2-benzopyran: a potent and selective D1 agonist

28 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum.

28 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--1. Identification and characterization.

28 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

Neural control of adenylate cyclase responsiveness in brown adipose tissue

28 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin

28 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

[125I]SCH 23982, a ‘selective’ D-1 receptor antagonist, labels with high affinity 5-HT1C sites in pig choroid plexus

28 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

Multiple receptors for dopamine

28 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

A-69024: a non-benzazepine antagonist with selectivity for the dopamine D-1 receptor

28 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

Stereoselective reversal of MPTP-induced parkinsonism in the marmoset after dermal application of N-0437.

28 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

Dihydrexidine, a novel selective high potency full dopamine D-1 receptor agonist

28 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors.

28 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

Persistence of neurochemical changes in dopamine systems after repeated cocaine administration

28 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system.

28 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

The central effects of a novel dopamine agonist

28 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

The characteristics of adrenoceptors in homogenates of human cerebral cortex labelled by (3H)-rauwolscine.

28 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures

28 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions.

28 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

A double-blind, placebo-controlled, dose-ranging study to investigate the safety and efficacy of CY 208-243 in patients with Parkinson's disease

28 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist

28 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

Dopamine receptors in the retina may all be linked to adenylate cyclase

28 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

Selective down-regulation of D1 dopamine mediated rotational behavior in supersensitive mice

28 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

Effect of continuous exposure to selective D1 and D2 dopaminergic agonists on rotational behavior in supersensitive mice

28 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

DSP4-induced noradrenergic lesions increase beta-adrenergic receptors and hippocampal electrophysiological responsiveness.

28 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90459-4

28 October 2022

Identifiers

1 reference

2 August 2017

1 reference